Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

(Image: Getty/KavalenkavaVolha)

GE Healthcare anticipates demand with Swiss facility investment

GE Healthcare reacts to the number of regenerative medicine companies operating globally by announcing plans for a facility to create single-use kits and advanced therapies.

PACT Pharma raises $75M to expand cell therapy manufacturing

PACT Pharma reels in Series C financing round to support expansion of cell therapy manufacturing capacity.

Boom in number of UK cell and gene therapy clinical trials

Year-on-year, the number of trials for advanced therapeutics has doubled, meaning that the UK now represents 12% of all global clinical trials in the area.

Health plan hails success of push to boost Remicade biosimilar use

Health New England switched 93% of infliximab use to biosimilars after adopting a new policy.

Celltrion set to build largest biopharma plant in China

The South Korean company plans to invest ₩600bn over a five-year period to support the construction of its first facility in China.

Global Industry News

Hot Topics

Spotlight

(Image: Getty/Lovelyday12)

Sarepta tips Roche pact to spur manufacturing capacity expansion

(Image: Getty/Peshkova)

Nationwide Children’s Hospital creates for-profit gene therapy CMO

(Image: Getty/C5Media)

Failure to launch? Mixed views on US biosimilar market

(Image: Getty/AlxeyPnferov)

WuXi Biologics acquires first EU drug product facility through Bayer deal

(Image: Getty/Panama7)

Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany

Follow us

Products

View more

Webinars

On-demand webinars

Marken Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories